Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMWH for Adenomyosis Patients in IVF-ET
NCT04741295Unknown
- Sponsor
- Nanjing University
- Start
- Feb 2020
- Primary completion
- Jan 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of low molecular weight heparin calcium in adenomyosis, sponsored by Nanjing University. Primary endpoint: Early spontaneous abortion rate at 12 weeks. Status: unknown.
02
Drugs
low molecular weight heparin calcium
03
Conditions
adenomyosis
Beyond the preview
Go deeper on NCT04741295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04741295.